# FEB 2 4 2012 K113190

<table><tr><td rowspan=2 colspan=1>Meridian</td><td rowspan=1 colspan=2>510(k) Application TRU Legionella</td></tr><tr><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=2 colspan=1>Bioscience, Inc.</td><td rowspan=1 colspan=1>Identification:</td><td rowspan=1 colspan=1>Attachment 002</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

510(k) number:

# Date of Preparation: October 28, 2011

Submitter: Submitter's address:

Meridian Bioscience, Inc   
3471 River Hilis Drive   
Cincinnati, Ohio 45244   
Susan Bogar   
(513) 271-3700

Contact: Contact number:

Device name: Common name: Classification:

TRU Legionella Device Legionella, Spp., Elisa Haemophilus spp serological reagents MJH, CFR Section 866.3300

# Predicate device:

K982238: Binax NOW® Legionella

Reference comparator:

Binax NOW® Legionella

# Description of the Device

T     l pohla ogrouantgen uman urie secens. The assy consstsTest Srps cntaini - Legionella pneumophila serogroup 1 as the capture antibody, Conjugate Tubes containing anti-legionella pnemophila serogroup 1 as the detection antibody, Sample Diluent/Negative Control, and Positive Control.

# Intended Use

TT ru  nen umn ueens. It is es  et secens m patts w ul  no h a o e us i njcion wi inoatin tai o he pati cnl valation nd erdc procedures.

<table><tr><td rowspan=2 colspan=2>Meridian</td><td rowspan=1 colspan=2>510(k) Application TRU Legionella</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=2 colspan=2>Bioscience, Inc.</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Identification:</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

Table 1: Comparison to Predicate Device   

<table><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">TRU Legionella</td><td colspan="1" rowspan="1">BinaxNOw° Legionella</td></tr><tr><td colspan="1" rowspan="1">Test Format</td><td colspan="1" rowspan="1">Rapid lateral flow immunoassay</td><td colspan="1" rowspan="1">Rapid immunochromatographic membraneassay</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Qualitative/Quantitative</td><td colspan="1" rowspan="1">Qualitative</td><td colspan="1" rowspan="1">Qualitative</td></tr><tr><td colspan="1" rowspan="1">Target Antigen</td><td colspan="1" rowspan="1">Legionella pneumophila serogroup 1</td><td colspan="1" rowspan="1">Legionella pneumophila serogroup 1</td></tr><tr><td colspan="1" rowspan="1">Specimen Types</td><td colspan="1" rowspan="1">Human urine, preserved and unpreserved</td><td colspan="1" rowspan="1">Human urine, preserved and unpreserved</td></tr><tr><td colspan="1" rowspan="1">Reagents/Components</td><td colspan="1" rowspan="1">Test StripConjugate TubeSample Diluent/Negative ControlPositive ControlPlastic transfer pipettes with 100, 200 and300 μL volume marks</td><td colspan="1" rowspan="1">Test DeviceReagent APositive Control SwabNegative Control SwabSwabs</td></tr><tr><td colspan="1" rowspan="1">Antibody Sources</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Test Card</td><td colspan="1" rowspan="1">Rabbit polyclonal</td><td colspan="1" rowspan="1">Rabbit polyclonal</td></tr><tr><td colspan="1" rowspan="1">Conjugate</td><td colspan="1" rowspan="1">Rabbit polyclonal</td><td colspan="1" rowspan="1">Polyclonal</td></tr><tr><td colspan="1" rowspan="1">Sample Preparation</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">Unpreserved and preserved urine</td><td colspan="1" rowspan="1">1. Add 100 μL of Sample Diluent toConjugate Tube. Vortex for 10 seconds.2. Add 100 μL of thoroughty mixed urinesample to the Conjugate Tube.3. Mix sample and conjugate thoroughly.</td><td colspan="1" rowspan="1">1. Dip swab into the urine sample and theninsert swab into the bottom hole of the TestDevice.2. Add 2 drops of Reagent A to the bottomhole.</td></tr><tr><td colspan="1" rowspan="1">Testing Time</td><td colspan="1" rowspan="1">Approximately 20 minutes</td><td colspan="1" rowspan="1">Approximately 15 minutes</td></tr><tr><td colspan="1" rowspan="1">Equipment</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">General Laboratory Equipment</td><td colspan="1" rowspan="1">VortexInterval timerDisposable latex gloves</td><td colspan="1" rowspan="1">TimerUrine collection containerBinaxNOw® Legionella Urinary AntigenControl Swab Pack</td></tr><tr><td colspan="1" rowspan="1">Reading Method</td><td colspan="1" rowspan="1">Visual</td><td colspan="1" rowspan="1">Visual</td></tr><tr><td colspan="1" rowspan="1">Results Interpretation</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Visual Read</td><td colspan="1" rowspan="1">Negative: A PINK-RED band at the ControlLine position. No other bands are present.Positive: PINK-RED band of any colorintensity at the Control and Legionella TestLine positions.Invalid: No band at the Control Lineposition, a pink-red band appearing after21 minutes of incubation, or a band of anyother color than pink-red.</td><td colspan="1" rowspan="1">Negative: Single pink to purple coloredControl line visible in the top half of thewindow.Positive: Two pink to purple colored lines.Invalid: No line at the Control Line positionor no lines at the Control or Sample Linepositions.</td></tr><tr><td colspan="1" rowspan="2">Meridian</td><td colspan="2" rowspan="1">510(k) Application TRU Legionella</td></tr><tr><td colspan="1" rowspan="1">Description:</td><td colspan="1" rowspan="1">510(k) Summary</td></tr><tr><td colspan="1" rowspan="2">Bioscience, Inc.</td><td colspan="1" rowspan="1">Identification:</td><td colspan="1" rowspan="1">Attachment 002</td></tr><tr><td colspan="1" rowspan="1">Date:</td><td colspan="1" rowspan="1">October 28, 2011</td></tr></table>

# Performance Comparison, Non-Clinical Tests

# Analytical Sensitivity

Sensitivity studies were designed to determine with $9 5 \%$ confidence the analytical limit of detection (LoD) of L. l assay was based on 45 replicates for each measurand and with a stated probability $( 9 5 \% )$ of obtaining positive responses at the following levels of the measurand shown in Table 1.

Table 2: Analytical Sensitivity   

<table><tr><td rowspan=1 colspan=1>Strain ID</td><td rowspan=1 colspan=1>Limit of Detection (LoD)</td></tr><tr><td rowspan=1 colspan=1>Philadeiphia strain (Pontiac subgroup; ATCC 33152)</td><td rowspan=1 colspan=1>3.76 x 10 CFU/mL</td></tr><tr><td rowspan=1 colspan=1>Bellingham strain (non-Pontiac subgroup; NCTC 11404)</td><td rowspan=1 colspan=1>5.2 x 10^3 CFU/mL</td></tr></table>

# Interference Testing

S p avn  atuiv postive samples. The contrived positive samples were prepared by spikig confirmed negative samples with Legionella pneumophila Philadeiphia strain antigen at $3 . 7 6 \times 1 0 ^ { 5 } C F U / m L$ the limit of detection for this assay. substance.

T  i results in the final concentrations listed:

Antihistamine $( 0 . 2 2 m g / m L )$ ,Ascorbic acid $( 1 . 0 m g / m L )$ Bilirubin $( 0 . 2 m g / m L )$ , Boric acid $( 2 . 6 3 m g / m L )$ Ciprofloxacin $( 0 . 2 2 \ m g / m L )$ , Cold and flu tablets $( 5 0 m g / m l )$ ,Cough drops $\{ 0 . 2 2 \ m g / \mathfrak { m } \mathfrak { L } \}$ , Cough syrup (0.20 $m \in ( m L )$ ,Decongestant $( 0 . 2 2 m g / m L )$ ,Erythromycin $( 0 . 0 6 7 m g / m L )$ , Glucose (20 mg/mL), Protein (BSA) $( 5 m g / m L )$ Rifampicin $\{ 0 . 0 9 m g / m L \}$ , Urea $( 2 0 m g / m L ) ,$ White blood cells $( 1 0 \% )$ Whole blood $( 1 0 \% )$ .

# Cross-reactivity Study

i suspected of having L. pneumophila infection were added at a final concentration of $1 . 2 \times 1 0 ^ { 8 } ( F U / m L$ (bacteria or fungi) or a final concentration greater than $1 \times 1 0 ^ { 5 } T C l D _ { 5 0 } / m L$ (viruses) to a pooled negative and a contrived i    at a contrived positive sample was prepared by spiking a confirmed negative sample with Legionella pneumohila Philadelphia strain antigen at $3 . 7 6 \times 1 0 ^ { 5 } ( F U / m L$ , the limit of detection for this assay. Dilution controls for each sample were prepared by addinga salne solution in placeof he potentially cross-reactive organisms.

<table><tr><td rowspan=2 colspan=2>Meridian</td><td rowspan=1 colspan=2>510(k) Application TRU Leglonella</td></tr><tr><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=2 colspan=2>Bioscience, Inc.</td><td rowspan=1 colspan=1>Identification:</td><td rowspan=1 colspan=1>Attachment 002</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

Toni n T L As ecBaciu c BaciubtiCnCn aaaCn p, ntEac Echerichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella bozemani, Legionella dumoffi, Legnellafeelei, Legionellagormani, Legionellalongbeachae, Legionellaicdade, Legionella neumophila serogroup 2, Legionella pneumophila serogroup 3, Legionella pneumophila serogroup 4, Legionella pneumophila serrup 5, Leginella peuophila ogrou 6, Morganellamorgani, Moraxellasenss, Nocardia astodes, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Serratia liquefaciens, Serratia marcescens, u $G ,$ Streptococcus pneumoniae, Adenovirus, Coxsackievirus, Infuenza A, Influenza B, Parainfluenza Virus, Respiratory Syncytial Virus A, Respiratory Syncytial Virus B.

# Strain Reactivity

T o      i concentrations of $4 . 8 \times 1 0 ^ { 6 } ( F U / m L$ or lower with the TRU Legionella assay:

Pon subgroup: CCUG 13395; NCTC 12024, Allentown 1; NCTC 12006, Benidorm; CCUG 33058, Knoxvile; NCTC 12007, France.

Non-Pontiac subgroup: NCTC 12008, OLDA; NCTC 12098, Camperdown; NCTC 12025, Heysham; NCTC 12009, Oxford. •

# Performance Comparison, Clinical Tests

Ccal    eg s wu e 0 the TRU Legionella assay were determined by comparison to the Binax NOW Legionella Urinary Antigen test. Inepnen cical est i catne Suhes n Miwe eginhe niStats nt   ean va    al pat va iv were samples that had been previousy sbmitted or Leginella testing. The sie locatd in the Netheands evaluated 20 frozen samples, chosen from a well characterized repository o urie samples colecte frm pats wi cegi Dis s wel  etiv eenso patnt s by Legionella. Samples were collected from 272 $( 6 3 . 6 \% )$ males and 134 $( 3 1 . 3 \% )$ females. The age groups of patients ranged from 6 years to 96 years. Overall positive percent agreement was determined to be $9 6 . 3 \%$ ;overall negative percent agreement was determined to be $100 . 0 \%$ Subsequent tables show overall assay performance as well as performance by clinical site.

<table><tr><td rowspan=2 colspan=2>Meridian</td><td rowspan=1 colspan=2>510(k) Application TRU Leglonella</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=2 colspan=2>Bioscience, Inc.</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Identification:</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

Table : Comparison f TRU Legionella to Binax NOW Legionella (Retrospective and Prospective Specimens)   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>TRU Legionella</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Binax NOW</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>131</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>136</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>292</td><td rowspan=1 colspan=1>292</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>131</td><td rowspan=1 colspan=1>297</td><td rowspan=1 colspan=1>428</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>95% Cl</td></tr><tr><td rowspan=1 colspan=1>Positive Agreement</td><td rowspan=1 colspan=1>131/136</td><td rowspan=1 colspan=1>96.3%</td><td rowspan=1 colspan=1>91.7 - 98.4%</td></tr><tr><td rowspan=1 colspan=1>Negative Agreement</td><td rowspan=1 colspan=1>292/292</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98.7 - 100.0%</td></tr><tr><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>423/428</td><td rowspan=1 colspan=1>98.8%</td><td rowspan=1 colspan=1>97.3 - 99.5%</td></tr></table>

Table 4: Performance Characteristics by Site (Retrospective and Prospective Specimens)   

<table><tr><td rowspan=1 colspan=1>Clinical TrialSite</td><td rowspan=1 colspan=1>TRULegionella/Binax NOW</td><td rowspan=1 colspan=1>PositiveAgreement(%)</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>TRULegionella/Binax NOW</td><td rowspan=1 colspan=1>NegativeAgreement(%)</td><td rowspan=1 colspan=1>95% CI</td></tr><tr><td rowspan=1 colspan=1>Site 1</td><td rowspan=1 colspan=1>6/6</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>61.0- 100.0%</td><td rowspan=1 colspan=1>60/60</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94.0 - 100.0%</td></tr><tr><td rowspan=1 colspan=1>Site 2</td><td rowspan=1 colspan=1>103/108</td><td rowspan=1 colspan=1>95.4%</td><td rowspan=1 colspan=1>89.6-98.0%</td><td rowspan=1 colspan=1>104/104</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>96.4 - 100.0%</td></tr><tr><td rowspan=1 colspan=1>Site 3</td><td rowspan=1 colspan=1>3/3</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>43.9 - 100.0%</td><td rowspan=1 colspan=1>78/78</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>93.5 - 100.0%</td></tr><tr><td rowspan=1 colspan=1>Site 4</td><td rowspan=1 colspan=1>19/19</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83.2 - 100.0%</td><td rowspan=1 colspan=1>50/50</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>92.9 - 100.0%</td></tr></table>

# Reproducibility

Rb p  p l   p nly wih  pl asents.  p con   nivmeaty p sns  criv lo posiv mples 3 criv s tai Legnelativ ees e ass cut an atual egativ peen nl we esat r epenn abo; p    a reproducibility study was $1 0 0 \% \left( 9 8 . 7 - 1 0 0 . 0 \% \right)$ .The correlation between expected and achieved results for the moderate positive, low positive and weak negative specimens was $100 . 0 \%$ EPY $( 9 8 . 2 - 1 0 0 . 0 \% )$ . The correlation for the high negative specimen was $1 0 0 . 0 \%$ EPY $( 9 5 . 9 - 1 0 0 . 0 \% )$ .Tables 5-7 contain the reproducibility data for the three sites.

<table><tr><td rowspan=4 colspan=1>MeridianBioscience, Inc.</td><td rowspan=1 colspan=2>510(k) Application TRU Legionella</td></tr><tr><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=1 colspan=1>Identification:</td><td rowspan=1 colspan=1>Attachment 002</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

<table><tr><td rowspan=5 colspan=1>Sample ID</td><td rowspan=5 colspan=1>Sample Result</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=4 colspan=1>Day 1Run 1(HBD-S)*</td><td rowspan=3 colspan=1>Day 1Run 2</td><td rowspan=3 colspan=1>Day 2Run 1</td><td rowspan=3 colspan=1>Day 2Run 2</td><td rowspan=3 colspan=1>Day 3Run 1</td><td rowspan=3 colspan=1>Day 3Run 2</td><td rowspan=3 colspan=1>Day 4Run 1</td><td rowspan=3 colspan=1>Day 4Run 2</td><td rowspan=2 colspan=1>Day 5</td><td rowspan=4 colspan=1>Day 5Run 2(DM)*</td></tr><tr></tr><tr><td rowspan=1 colspan=1>Run 1</td></tr><tr><td rowspan=1 colspan=1>(DM)*</td><td rowspan=1 colspan=1>(HBD-S)*</td><td rowspan=1 colspan=1>(DM)*</td><td rowspan=1 colspan=1>(HBD-S)*</td><td rowspan=1 colspan=1>(DM)*</td><td rowspan=1 colspan=1>(HBD-S)*</td><td rowspan=1 colspan=1>(DM)*</td><td rowspan=1 colspan=1>(HBD-S)*</td></tr><tr><td rowspan=1 colspan=1>Positive Control</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Negative Control</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 1</td><td rowspan=3 colspan=1>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 2</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 3</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 1</td><td rowspan=3 colspan=1>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 2</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 3</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>High Negative 1</td><td rowspan=3 colspan=1>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 2</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 3</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Negative 1</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=2>Percent Correlation</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=2>Correlation of cut off Specimens</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

aanpSan = San 'aaniod = cod :nuaSay

<table><tr><td rowspan=4 colspan=1>MeridianBioscience, Inc.</td><td rowspan=1 colspan=2>510(k) Application TRU Legionella</td></tr><tr><td rowspan=1 colspan=1>Description:</td><td rowspan=1 colspan=1>510(k) Summary</td></tr><tr><td rowspan=1 colspan=1>Identification:</td><td rowspan=1 colspan=1>Attachment 002</td></tr><tr><td rowspan=1 colspan=1>Date:</td><td rowspan=1 colspan=1>October 28, 2011</td></tr></table>

<table><tr><td rowspan=4 colspan=1>Sample ID</td><td rowspan=4 colspan=2>Sample Result</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=3 colspan=1>Day 1Run 1(CM)*</td><td rowspan=3 colspan=1>Day 1Run 2(LR)*</td><td rowspan=2 colspan=1>Day 2Run 1</td><td rowspan=2 colspan=1>Day 2Run 2</td><td rowspan=2 colspan=1>Day 3Run 1</td><td rowspan=2 colspan=1>Day 3Run 2</td><td rowspan=2 colspan=1>Day 4.Run 1</td><td rowspan=2 colspan=1>Day 4Run 2</td><td rowspan=2 colspan=1>Day 5Run 1</td><td rowspan=3 colspan=1>Day 5Run 2(LR)*</td></tr><tr></tr><tr><td rowspan=1 colspan=1>(CM)*</td><td rowspan=1 colspan=1>(LR)*</td><td rowspan=1 colspan=1>(CM)*</td><td rowspan=1 colspan=1>{LR)*</td><td rowspan=1 colspan=1>(CM)*</td><td rowspan=1 colspan=1>(LR)*</td><td rowspan=1 colspan=1>(CM)*</td></tr><tr><td rowspan=1 colspan=1>Positive Control</td><td rowspan=1 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td></tr><tr><td rowspan=1 colspan=1>Negative Control</td><td rowspan=1 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 1</td><td rowspan=3 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 2</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 3</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 1</td><td rowspan=2 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 2</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 3</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td></tr><tr><td rowspan=1 colspan=1>High Negative 1</td><td rowspan=3 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 2</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 3</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Negative 1</td><td rowspan=1 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=3>Percent Correlation</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=3>Correlation of cut off Specimens</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>0 2 q</td><td rowspan=1 colspan=1>Cefe</td><td rowspan=4 colspan=2>e cgWelir</td></tr><tr><td rowspan=1 colspan=1>Aa0 Aecmn0</td><td rowspan=1 colspan=1>iangi</td></tr><tr><td rowspan=1 colspan=1>Sewwns (x)ons</td><td rowspan=1 colspan=1>Codg</td></tr><tr><td rowspan=1 colspan=2>Suoi Td ondd (oe</td></tr></table>

<table><tr><td rowspan=4 colspan=1>Sample iD</td><td rowspan=4 colspan=2>Sample Result</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=3 colspan=1>Day 1Run 1(BD)*</td><td rowspan=2 colspan=1>Day 1Run 2</td><td rowspan=2 colspan=1>Day 2Run 1</td><td rowspan=2 colspan=1>Day 2Run 2</td><td rowspan=2 colspan=1>Day 3Run 1</td><td rowspan=2 colspan=1>Day 3Run 2</td><td rowspan=2 colspan=1>Day 4Run 1</td><td rowspan=2 colspan=1>Day 4Run 2</td><td rowspan=2 colspan=1>Day 5Run 1</td><td rowspan=3 colspan=1>Day 5Run 2{JH)</td></tr><tr></tr><tr><td rowspan=1 colspan=1>(JH)</td><td rowspan=1 colspan=1>(BD)*</td><td rowspan=1 colspan=1>(JH)</td><td rowspan=1 colspan=1>(BD)*</td><td rowspan=1 colspan=1>(JH)</td><td rowspan=1 colspan=1>(BD)*</td><td rowspan=1 colspan=1>(JH)</td><td rowspan=1 colspan=1>(BD)*</td></tr><tr><td rowspan=1 colspan=1>Positive Control</td><td rowspan=1 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Negative Control</td><td rowspan=1 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 1</td><td rowspan=2 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Moderate Positive 3</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 1</td><td rowspan=2 colspan=2>Positive</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POs</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 2</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Low Positive 3</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>High Negative 1</td><td rowspan=2 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 2</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>High Negative 3</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=1>Negative 1</td><td rowspan=1 colspan=2>Negative</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td></tr><tr><td rowspan=1 colspan=3>Percent Correlation</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=3>Correlation of cut off Specimens</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

Meridian Bioscience, Inc.   
$\mathbf { c / o }$ Ms. Susan Bogar   
Product Quality Assurance Manager 3471 River Hills Drive   
Cincinnati, OH 45244

Re: K113190 Trade/Device Name: TRU Legionella assay Regulation Number: 21 CFR 866.3300 Regulation Name: Haemophilus spp. Serological Reagents Regulatory Class: Class II Product Code: MJH Dated: January 26, 2012 Received: January 27, 2012

Dear Ms. Bogar:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class Ⅱ (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice

requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796- 5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Nar, a

Sally A. Hojvat, M.Sc., Ph.D.   
Director   
Division of Microbiology Devices   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indications for Use Form

510(k) Number (if known): K113190

Indications for Use:

The TRU Legionella assay is an in vitro, rapid, lateral-flow immunoassay for the qualitative detection of Legionella pneumophila serogroup 1 antigens in human urine specimens. It is designed to test specimens from patients with symptoms of pneumonia. Test results are to be used as an aid in diagnosis of Legionella pneumophila serogroup 1 infection. A negative result does not preclude infection with Legionella pneumophila serogroup 1. Test results are to be used in conjunction with information obtained from the patient's clinical evaluation and other diagnostic procedures.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety